Antiproliferative Effect of Vine Stem Extract from Spatholobus Suberectus Dunn on Rat C6 Glioma Cells Through Regulation of ROS, Mitochondrial Depolarization, and P21 Protein Expression

References

• Ostrom QT, Gittleman H, Fulop J, Liu M, Blanda R, et al.: CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2008–2012. Neuro Oncol 17(Suppl 4), iv1–iv62, 2015. doi:10.1093/neuonc/nov189.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, and Jemal A: Cancer statistics, 2015. CA Cancer J Clin 65, 5–29, 2015. doi:10.3322/caac.21254.
   PubMed Web of Science ®Google Scholar
• Huang R, Ke W, Han L, Li J, Liu S, et al.: Targeted delivery of chlorotoxin-modified DNA-loaded nanoparticles to glioma via intravenous administration. Biomaterials 32, 2399–2406, 2011. doi:10.1016/j.biomaterials.2010.11.079.
   PubMed Web of Science ®Google Scholar
• Simon HU, Haj-Yehia A, and Levi-Schaffer F: Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 5, 415–418, 2000. doi:10.1023/A:1009616228304.
   PubMed Web of Science ®Google Scholar
• Schumacker PT: Reactive oxygen species in cancer cells: live by the sword, die by the sword. Cancer Cell 10, 175–176, 2006. doi:10.1016/j.ccr.2006.08.015.
   PubMed Web of Science ®Google Scholar
• Wiseman H and Halliwell B: Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem J 313(Pt 1), 17–29, 1996. doi:10.1042/bj3130017.
   PubMed Web of Science ®Google Scholar
• Clerkin JS, Naughton R, Quiney C, and Cotter TG: Mechanisms of ROS modulated cell survival during carcinogenesis. Cancer Lett 266, 30–36, 2008. doi:10.1016/j.canlet.2008.02.029 .
   PubMed Web of Science ®Google Scholar
• Pelicano H, Carney D, and Huang P: ROS stress in cancer cells and therapeutic implications. Drug Resist Updat 7, 97–110, 2004. doi:10.1016/j.drup.2004.01.004.
   PubMed Web of Science ®Google Scholar
• Ray PD, Huang BW, and Tsuji Y: Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal 24, 981–990, 2012. doi:10.1016/j.cellsig.2012.01.008.
   PubMed Web of Science ®Google Scholar
• Yakes FM and Van Houten B: Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci U S A 94, 514–519, 1997. doi:10.1073/pnas.94.2.514.
   PubMed Web of Science ®Google Scholar
• Ziech D, Franco R, Pappa A, and Panayiotidis MI: Reactive oxygen species (ROS)–induced genetic and epigenetic alterations in human carcinogenesis. Mutat Res 711, 167–173, 2011. doi:10.1016/j.mrfmmm.2011.02.015.
   PubMed Web of Science ®Google Scholar
• Forcados GE, James DB, Sallau AB, Muhammad A, and Mabeta P: Oxidative stress and carcinogenesis: potential of phytochemicals in Breast Cancer Therapy. Nutr Cancer 69, 365–374, 2017. doi.org/10.1080/01635581.2017.1267777.
   PubMed Web of Science ®Google Scholar
• Owen RW, Giacosa A, Hull WE, Haubner R, Spiegelhalder B, et al.: The antioxidant/anticancer potential of phenolic compounds isolated from olive oil. Eur J Cancer 36, 1235–1247, 2000. doi:10.1016/S0959-8049(00)00103-9.
   PubMed Web of Science ®Google Scholar
• Trachootham D, Alexandre J, and Huang P: Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 8, 579–591, 2009. doi:10.1038/nrd2803.
   PubMed Web of Science ®Google Scholar
• Wang J and Yi J: Cancer cell killing via ROS: to increase or decrease, that is the question. Cancer Biol Ther 7, 1875–1884, 2008. doi:10.4161/cbt.7.12.7067.
   PubMed Web of Science ®Google Scholar
• Liu B, Tan X, Liang J, Wu S, Liu J, et al.: A reduction in reactive oxygen species contributes to dihydromyricetin-induced apoptosis in human hepatocellular carcinoma cells. Sci Rep 4, 7041, 2014. doi:10.1038/srep07041.
   PubMed Web of Science ®Google Scholar
• Jeong CH and Joo SH: Downregulation of reactive oxygen species in apoptosis. J Cancer Prev 21, 13–20, 2016. doi:10.15430/JCP.2016.21.1.13.
   PubMedGoogle Scholar
• Kim SJ, Hwang E, Yi SS, Song KD, Lee HK, et al.: Sea Buckthorn Leaf extract inhibits glioma cell growth by reducing reactive oxygen species and promoting apoptosis. Appl Biochem Biotechnol 182, 1663–1674, 2017. doi.org/10.1007/s12010-017-2425-4.
   Web of Science ®Google Scholar
• Pimm SL and Joppa LN: How many plant species are there, where are they, and at what rate are they going extinct? Annals of the Missouri Botanical Garden 100, 170–176, 2015. doi:10.3417/2012018.
   Web of Science ®Google Scholar
• Nobili S, Lippi D, Witort E, Donnini M, Bausi L, et al.: Natural compounds for cancer treatment and prevention. Pharmacol Res 59, 365–378, 2009. doi:10.1016/j.phrs.2009.01.017.
   PubMed Web of Science ®Google Scholar
• Reddy L, Odhav B, and Bhoola KD: Natural products for cancer prevention: a global perspective. Pharmacol Ther 99, 1–13, 2003. doi:10.1016/S0163-7258(03)00042-1.
   PubMed Web of Science ®Google Scholar
• Jeong JC, Jang SW, Kim TH, Kwon CH, and Kim YK: Mulberry fruit (Moris fructus) extracts induce human glioma cell death in vitro through ROS-dependent mitochondrial pathway and inhibits glioma tumor growth in vivo. Nutr Cancer 62, 402–412, 2010. doi:10.1080/01635580903441287.
   PubMed Web of Science ®Google Scholar
• Li RW, David Lin G, Myers SP, and Leach DN: Anti-inflammatory activity of Chinese medicinal vine plants. J Ethnopharmacol 85, 61–67, 2003. doi:10.1016/S0378-8741(02)00339-2.
   PubMed Web of Science ®Google Scholar
• Pang J, Guo JP, Jin M, Chen ZQ, Wang XW, et al.: Antiviral effects of aqueous extract from Spatholobus suberectus Dunn. Against coxsackievirus B3 in mice. Chin J Integr Med 17, 764–769, 2011. doi:10.1007/s11655-011-0642-1.
   PubMed Web of Science ®Google Scholar
• Wang DX, Liu P, Chen YH, Chen RY, Guo DH, et al.: Stimulating effect of catechin, an active component of Spatholobus suberectus Dunn, on bioactivity of hematopoietic growth factor. Chin Med J (Engl) 121, 752–755, 2008.
   PubMed Web of Science ®Google Scholar
• Chen SR, Wang AQ, Lin LG, Qiu HC, Wang YT, et al.: In vitro study on anti-hepatitis C virus activity of Spatholobus suberectus Dunn. Molecules 21, 1367, 2016. doi:10.3390/molecules21101367.
   PubMed Web of Science ®Google Scholar
• Zhang R, Liu C, Liu X, Guo Y: Protective effect of Spatholobus suberectus on brain tissues in cerebral ischemia. Am J Transl Res 8, 3963–3969, 2016.
   PubMed Web of Science ®Google Scholar
• Fu Q, Tang Y, Luo X, Yang G, He W, et al.: Anti-tumor activity and mechanism with SSCE of Spatholobus suberctus. Zhongguo Zhong Yao Za Zhi 34, 1570–1573, 2009.
   PubMedGoogle Scholar
• Peng F, Meng CW, Zhou QM, Chen JP, and Xiong L: Cytotoxic evaluation against breast cancer cells of Isoliquiritigenin analogues from spatholobus suberectus and their synthetic derivatives. J Nat Prod 79, 248–251, 2016. doi:10.1021/acs.jnatprod.5b00774.
   PubMed Web of Science ®Google Scholar
• Wang ZY, Wang DM, Loo TY, Cheng Y, Chen LL, et al.: Spatholobus suberectus inhibits cancer cell growth by inducing apoptosis and arresting cell cycle at G2/M checkpoint. J Ethnopharmacol 133, 751–758, 2011. doi:10.1016/j.jep.2010.11.004.
   PubMed Web of Science ®Google Scholar
• Tang Y, Fu Q, He W, Sun YK, Wang YZ, et al.: Non-apoptotic programmed cell death induced by extract of Spatholobus suberctus in human lung cancer A549 cells. Zhongguo Zhong Yao Za Zhi 33, 2040–2044, 2008.
   PubMedGoogle Scholar
• Cui YJ, Liu P, and Chen RY: Studies on the chemical constituents of Spatholobus suberectus Dunn. Yao Xue Xue Bao 37, 784–787, 2002.
   PubMedGoogle Scholar
• Yoon JS, Sung SH, Park JH, and Kim YC: Flavonoids from Spatholobus suberectus. Arch Pharm Res 27, 589–592, 2004. doi:10.1007/BF02980154.
   PubMed Web of Science ®Google Scholar
• Tang RN, Qu XB, Guan SH, Xu PP, Shi YY, et al.: Chemical constituents of Spatholobus suberectus. Chin J Nat Med 10, 32–35, 2012. doi:10.1016/S1875-5364(12)60007-7 doi.org/10.3724/SP.J.1009.2012.00032.
   PubMed Web of Science ®Google Scholar
• Deeken JF and Loscher W: The blood-brain barrier and cancer: transporters, treatment, and Trojan horses. Clin Cancer Res 13, 1663–1674, 2007. doi:10.1158/1078-0432.CCR-06-2854.
   PubMed Web of Science ®Google Scholar
• Liu Y, Ran R, Chen J, Kuang Q, Tang J, et al.: Paclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targeting. Biomaterials 35, 4835–4847, 2014. doi:10.1016/j.biomaterials.2014.02.031.
   PubMed Web of Science ®Google Scholar
• Rong Y, Durden DL, Van Meir EG, and Brat DJ: ‘Pseudopalisading’ necrosis in glioblastoma: A familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis. J Neuropathol Exp Neurol 65, 529–539, 2006. doi:10.1097/00005072-200606000-00001.
   PubMed Web of Science ®Google Scholar
• Hassas-Roudsari M, Chang PR, Pegg RB, and Tyler RT: Antioxidant capacity of bioactives extracted from canola meal by subcritical water, ethanolic and hot water extraction. Food Chem 114, 717–726, 2009. doi:10.1016/j.foodchem.2008.09.097.
   Web of Science ®Google Scholar
• Dudonne S, Vitrac X, Coutiere P, Woillez M, and Merillon JM: Comparative study of antioxidant properties and total phenolic content of 30 plant extracts of industrial interest using DPPH, ABTS, FRAP, SOD, and ORAC assays. J Agric Food Chem 57, 1768–1774, 2009. doi:10.1021/jf803011r.
   PubMed Web of Science ®Google Scholar
• He Q, Yao K, Jia D, Fan H, Liao X, et al.: Determination of total catechins in tea extracts by HPLC and spectrophotometry. Nat Prod Res 23, 93–100, 2009. doi:10.1080/14786410801886682.
   PubMed Web of Science ®Google Scholar
• Miyake JA, Benadiba M, and Colquhoun A: Gamma-linolenic acid inhibits both tumour cell cycle progression and angiogenesis in the orthotopic C6 glioma model through changes in VEGF, Flt1, ERK1/2, MMP2, cyclin D1, pRb, p53 and p27 protein expression. Lipids Health Dis 8, 8, 2009. doi:10.1186/1476-511X-8-8.
   PubMed Web of Science ®Google Scholar
• Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402–408, 2001. doi:10.1006/meth.2001.1262.
   PubMed Web of Science ®Google Scholar
• Hong M, Song KD, Lee HK, Yi S, Lee YS, et al.: Fibrates inhibit the apoptosis of Batten disease lymphoblast cells via autophagy recovery and regulation of mitochondrial membrane potential. In Vitro Cell Dev Biol-Anim 52, 349–355, 2016. doi:10.1007/s11626-015-9979-7.
   PubMed Web of Science ®Google Scholar
• Cai Y, Luo Q, Sun M, and Corke H: Antioxidant activity and phenolic compounds of 112 traditional Chinese medicinal plants associated with anticancer. Life Sci 74, 2157–2184, 2004. doi:10.1016/j.lfs.2003.09.047.
   PubMed Web of Science ®Google Scholar
• Vistica DT, Skehan P, Scudiero D, Monks A, Pittman A, et al.: Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production. Cancer Res 51, 2515–2520, 1991.
   PubMed Web of Science ®Google Scholar
• Ren Y, Zhou X, Mei M, Yuan XB, Han L, et al.: MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol. BMC Cancer 10, 27, 2010. doi:10.1186/1471-2407-10-27.
   PubMed Web of Science ®Google Scholar
• Kondo Y, Kondo S, Tanaka Y, Haqqi T, Barna BP, et al.: Inhibition of telomerase increases the susceptibility of human malignant glioblastoma cells to cisplatin-induced apoptosis. Oncogene 16, 2243–2248, 1998. doi:10.1038/sj.onc.1201754.
   PubMed Web of Science ®Google Scholar
• Sanchez-Perez I and Perona R: Lack of c-Jun activity increases survival to cisplatin. FEBS Lett 453, 151–158, 1999. doi:10.1016/S0014-5793(99)00690-0.
   PubMed Web of Science ®Google Scholar
• Evan GI and Vousden KH: Proliferation, cell cycle and apoptosis in cancer. Nature 411, 342–348, 2001. doi:10.1038/35077213.
   PubMed Web of Science ®Google Scholar
• Waldman T, Zhang Y, Dillehay L, Yu J, Kinzler K, et al.: Cell-cycle arrest versus cell death in cancer therapy. Nat Med 3, 1034–1036, 1997. doi:10.1038/nm0997-1034.
   PubMed Web of Science ®Google Scholar
• Gomes A, Fernandes E, and Lima JLFC: Fluorescence probes used for detection of reactive oxygen species. J Biochem Biophys Methods 65, 45–80, 2005. doi:10.1016/j.jbbm.2005.10.003.
   PubMedGoogle Scholar
• Salvioli S, Ardizzoni A, Franceschi C, and Cossarizza A: JC-1, but not DiOC6(3) or rhodamine 123, is a reliable fluorescent probe to assess delta psi changes in intact cells: implications for studies on mitochondrial functionality during apoptosis. FEBS Lett 411, 77–82, 1997. doi:10.1016/S0014-5793(97)00669-8.
   PubMed Web of Science ®Google Scholar
• Guo YF, Xiao P, Lei SF, Deng FY, Xiao GG, et al.: How is mRNA expression predictive for protein expression? A correlation study on human circulating monocytes. Acta Biochimica Et Biophysica Sinica 40, 426–436, 2008. doi:10.1111/j.1745-7270.2008.00418.x.
   PubMed Web of Science ®Google Scholar
• Ruch RJ, Cheng SJ, and Klaunig JE: Prevention of cytotoxicity and inhibition of intercellular communication by antioxidant catechins isolated from Chinese green tea. Carcinogenesis 10, 1003–1008, 1989. doi:10.1093/carcin/10.6.1003.
   PubMed Web of Science ®Google Scholar
• Galati G and O'Brien PJ: Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties. Free Radic Biol Med 37, 287–303, 2004. doi:10.1016/j.freeradbiomed.2004.04.034.
   PubMed Web of Science ®Google Scholar
• Havsteen BH: The biochemistry and medical significance of the flavonoids. Pharmacol Ther 96, 67–202, 2002. doi:10.1016/S0163-7258(02)00298-X.
   PubMed Web of Science ®Google Scholar
• Middleton E, Jr., Kandaswami C, and Theoharides TC: The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 52, 673–751, 2000.
   PubMed Web of Science ®Google Scholar
• Kumar S and Pandey AK: Chemistry and biological activities of flavonoids: an overview. Sci World J 2013, 162750, 2013. doi:10.1155/2013/162750.
   Web of Science ®Google Scholar
• Normen L, Johnsson M, Andersson H, van Gameren Y, and Dutta P: Plant sterols in vegetables and fruits commonly consumed in Sweden. Eur J Nutr 38, 84–89, 1999. doi:10.1007/s003940050048.
   PubMed Web of Science ®Google Scholar
• Hrabovski N, Sinadinovic-Fiser S, Nikolovski B, Sovilj M, and Borota O: Phytosterols in pumpkin seed oil extracted by organic solvents and supercritical CO2. Eur J Lipid Sci Technol 114, 1204–1211, 2012. doi:10.1002/ejlt.201200009.
   Web of Science ®Google Scholar
• Kimura ET, Ebert DM, and Dodge PW: Acute toxicity and limits of solvent residue for sixteen organic solvents. Toxicol Appl Pharmacol 19, 699–704, 1971. doi:10.1016/0041-008X(71)90301-2.
   PubMed Web of Science ®Google Scholar
• Ling WH, and Jones PJ: Dietary phytosterols: a review of metabolism, benefits and side effects. Life Sci 57, 195–206, 1995. doi:10.1016/0024-3205(95)00263-6.
   PubMed Web of Science ®Google Scholar
• Woyengo TA, Ramprasath VR, and Jones PJ: Anticancer effects of phytosterols. Eur J Clin Nutr 63, 813–820, 2009. doi:10.1038/ejcn.2009.29.
   PubMed Web of Science ®Google Scholar
• Lindley C, McCune JS, Thomason TE, Lauder D, Sauls A, et al.: Perception of chemotherapy side effects cancer versus noncancer patients. Cancer Pract 7, 59–65, 1999. doi:10.1046/j.1523-5394.1999.07205.x.
   PubMedGoogle Scholar
• Taixiang W, Munro AJ, and Guanjian L: Chinese medical herbs for chemotherapy side effects in colorectal cancer patients. Cochrane Database Syst Rev 25, CD004540, 2005. doi:10.1002/14651858.CD004540.pub2.
   PubMed Web of Science ®Google Scholar
• Shu X, McCulloch M, Xiao H, Broffman M, and Gao J: Chinese herbal medicine and chemotherapy in the treatment of hepatocellular carcinoma: a meta-analysis of randomized controlled trials. Integr Cancer Ther 4, 219–229, 2005. doi:10.1177/1534735405279927 doi.org/10.1177/1534735405279927.
   PubMedGoogle Scholar
• Qi F, Li A, Inagaki Y, Gao J, Li J, et al.: Chinese herbal medicines as adjuvant treatment during chemo- or radio-therapy for cancer. Biosci Trends 4, 297–307, 2010.
   PubMed Web of Science ®Google Scholar
• Fleischer T, Chang TT, Chiang JH, Sun MF, and Yen HR: Improved survival with integration of Chinese herbal medicine therapy in patients with acute Myeloid Leukemia: a nationwide population-based cohort study. Integr Cancer Ther 16, 156–164, 2016. doi:10.1177/1534735416664171.
   PubMed Web of Science ®Google Scholar
• Porter AG and Janicke RU: Emerging roles of caspase-3 in apoptosis. Cell Death Differ 6, 99–104, 1999. doi:10.1038/sj.cdd.4400476.
   PubMed Web of Science ®Google Scholar
• Valko M, Rhodes CJ, Moncol J, Izakovic M, and Mazur M: Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 160, 1–40, 2006. doi:10.1016/j.cbi.2005.12.009.
   PubMed Web of Science ®Google Scholar
• Suzuki N, Miller G, Morales J, Shulaev V, Torres MA, et al.: Respiratory burst oxidases: the engines of ROS signaling. Curr Opin Plant Biol 14, 691–699, 2011. doi:10.1016/j.pbi.2011.07.014.
   PubMed Web of Science ®Google Scholar
• Mittler R, Vanderauwera S, Suzuki N, Miller G, Tognetti VB, et al.: ROS signaling: the new wave? Trends Plant Sci 16, 300–309, 2011. doi:10.1016/j.tplants.2011.03.007.
   PubMed Web of Science ®Google Scholar
• Gupta S: Molecular signaling in death receptor and mitochondrial pathways of apoptosis (Review). Int J Oncol 22, 15–20, 2003.
   PubMed Web of Science ®Google Scholar
• Zamzami N, Marchetti P, Castedo M, Decaudin D, Macho A, et al.: Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J Exp Med 182, 367–377, 1995. doi:10.1084/jem.182.2.367.
   PubMed Web of Science ®Google Scholar
• Heiskanen KM, Bhat MB, Wang HW, Ma J, and Nieminen AL: Mitochondrial depolarization accompanies cytochrome c release during apoptosis in PC6 cells. J Biol Chem 274, 5654–5658, 1999. doi:10.1074/jbc.274.9.5654.
   PubMed Web of Science ®Google Scholar
• Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, et al.: Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275, 1129–1132, 1997. doi:10.1126/science.275.5303.1129.
   PubMed Web of Science ®Google Scholar
• Wang G, Wang JJ, Chen XL, Du SM, Li DS, et al.: The JAK2/STAT3 and mitochondrial pathways are essential for quercetin nanoliposome-induced C6 glioma cell death. Cell Death Dis 4, e746, 2013. doi:10.1038/cddis.2013.242.
   PubMed Web of Science ®Google Scholar
• Twig G, Hyde B, and Shirihai OS: Mitochondrial fusion, fission and autophagy as a quality control axis: the bioenergetic view. Biochim Biophys Acta 1777, 1092–1097, 2008. doi:10.1016/j.bbabio.2008.05.001.
   PubMed Web of Science ®Google Scholar
• Twig G, Elorza A, Molina AJ, Mohamed H, Wikstrom JD, et al.: Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J 27, 433–446, 2008. doi:10.1038/sj.emboj.7601963.
   PubMed Web of Science ®Google Scholar
• Macleod KF, Sherry N, Hannon G, Beach D, Tokino T, et al.: p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev 9, 935–944, 1995. doi:10.1101/gad.9.8.935.
   PubMed Web of Science ®Google Scholar
• Abbas T and Dutta A: p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 9, 400–414, 2009. doi:10.1038/nrc2657.
   PubMed Web of Science ®Google Scholar
• Frankel RH, Bayona W, Koslow M, and Newcomb EW: p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency. Cancer Res 52, 1427–1433, 1992.
   PubMed Web of Science ®Google Scholar
• Muller PA and Vousden KH: p53 mutations in cancer. Nat Cell Biol 15, 2–8, 2013. doi:10.1038/ncb2641.
   PubMed Web of Science ®Google Scholar
• Polager S and Ginsberg D: p53 and E2f: partners in life and death. Nat Rev Cancer 9, 738–748, 2009. doi:10.1038/nrc2718.
   PubMed Web of Science ®Google Scholar
• Wu X and Levine AJ: p53 and E2F-1 cooperate to mediate apoptosis. Proc Natl Acad Sci U S A 91, 3602–3606, 1994. doi:10.1073/pnas.91.9.3602.
   PubMed Web of Science ®Google Scholar
• Hickman ES, Moroni MC, and Helin K: The role of p53 and pRB in apoptosis and cancer. Curr Opin Genet Dev 12, 60–66, 2002. doi:10.1016/S0959-437X(01)00265-9.
   PubMed Web of Science ®Google Scholar
• Zhu H, Zhang L, Wu S, Teraishi F, Davis JJ, et al.: Induction of S-phase arrest and p21 overexpression by a small molecule 2[[3-(2,3-dichlorophenoxy)propyl] amino]ethanol in correlation with activation of ERK. Oncogene 23, 4984–4992, 2004. doi:10.1038/sj.onc.1207645.
   PubMed Web of Science ®Google Scholar
• Prentice RL: A generalization of the probit and logit methods for dose response curves. Biometrics 32, 761–768, 1976. doi:10.2307/2529262.
   PubMed Web of Science ®Google Scholar
• Kalish LA: Efficient design for estimation of median lethal dose and quantal dose-response curves. Biometrics 46, 737–48, 1990. doi:10.2307/2532092.
   PubMed Web of Science ®Google Scholar
• Turner PV, Brabb T, Pekow C, and Vasbinder MA: Administration of substances to laboratory animals: routes of administration and factors to consider. J Am Assoc Lab Anim Sci 50, 600–613, 2011.
   PubMed Web of Science ®Google Scholar
• Chen L, Lee MJ, Li H, and Yang CS: Absorption, distribution, elimination of tea polyphenols in rats. Drug Metab Dispos 25, 1045–1050, 1997.
   PubMed Web of Science ®Google Scholar
• Miyazawa T: Absorption, metabolism and antioxidative effects of tea catechin in humans. Biofactors 13, 55–59, 2000. doi:10.1002/biof.5520130110.
   PubMed Web of Science ®Google Scholar
• Scalbert A, Morand C, Manach C, and Remesy C: Absorption and metabolism of polyphenols in the gut and impact on health. Biomed Pharmacother 56, 276–282, 2002. doi:10.1016/S0753-3322(02)00205-6.
   PubMed Web of Science ®Google Scholar
• Nair AB and Jacob S: A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm 7, 27–31, 2016. doi:10.4103/0976-0105.177703.
   PubMedGoogle Scholar
• Barnard R and Gurevich KG: In vitro bioassay as a predictor of in vivo response. Theor Biol Med Model 2, 3, 2005. doi:10.1186/1742-4682-2-3.
   PubMed Web of Science ®Google Scholar
• Spielmann H, Genschow E, Liebsch M, and Halle W: Determination of the starting dose for Acute Oral Toxicity (LD50) testing in the up and down procedure (UDP) from Cytotoxicity data. Altern Lab Anim 27, 957–966, 1999.
   PubMed Web of Science ®Google Scholar